SEARCH RESULTS FOR: 立陶宛U卡(www.usdtcard.org)Ms2M(9964 results)

Export results
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

MicroMatrix, 60 mg
ACELL, INC.
MM0060
Not in Commercial Distribution

  • 00386190000137 ()

  • Weight: 60 Milligram
MM0060

  • Animal-derived wound matrix dressing
MatriStem Wound Sheet, 10 X 15 cm
ACELL, INC.
WS1015
Not in Commercial Distribution

  • 00386190000113 ()

  • Rectangle device approximately 10 x 15 cm
WS1015

  • Animal-derived wound matrix dressing
MatriStem Wound Sheet, 7 X 10 cm
ACELL, INC.
WS0710
Not in Commercial Distribution

  • 00386190000090 ()

  • Rectangle device approximately 7 x 10 cm
WS0710

  • Animal-derived wound matrix dressing
MatriStem Wound Sheet, 3 X 7 cm
ACELL, INC.
WS0307
Not in Commercial Distribution

  • 00386190000076 ()

  • Rectangle device approximately 3 x 7 cm
WS0307

  • Animal-derived wound matrix dressing
MatriStem Wound Sheet, 3 X 3.5 cm
ACELL, INC.
WS0303
Not in Commercial Distribution

  • 00386190000052 ()

  • Rectangle device approximately 3 x 3.5 cm
WS0303

  • Animal-derived wound matrix dressing
MicroMatrix, 30 mg
ACELL, INC.
MM0030
Not in Commercial Distribution

  • 00386190000014 ()

  • Weight: 30 Milligram
MM0030

  • Animal-derived wound matrix dressing
MicroMatrix, 20 mg
ACELL, INC.
MM0020
Not in Commercial Distribution

  • 00386190000007 ()

  • Weight: 20 Milligram
MM0020

  • Animal-derived wound matrix dressing
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R090A
In Commercial Distribution

  • 04540778140875 ()
  • 14540778140872 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R105A
In Commercial Distribution

  • 04540778140868 ()
  • 14540778140865 ()

  • Length: 105 Millimeter


  • Lacrimal tube
CoCr sterile
Merete GmbH
Metatarsal 2
Not in Commercial Distribution

  • 04048266000972 ()

  • size: 2
FM20002

  • Partial metatarsophalangeal joint prosthesis
< 1 ... 723 724 725 726 727 ... 997 >